Fulgent Genetics (FLGT) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to -$380.9 million.
- Fulgent Genetics' Enterprise Value fell 7585.68% to -$380.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$380.9 million, marking a year-over-year decrease of 7585.68%. This contributed to the annual value of -$262.2 million for FY2024, which is 3859.62% up from last year.
- Per Fulgent Genetics' latest filing, its Enterprise Value stood at -$380.9 million for Q3 2025, which was down 7585.68% from -$297.9 million recorded in Q2 2025.
- In the past 5 years, Fulgent Genetics' Enterprise Value registered a high of -$216.6 million during Q3 2024, and its lowest value of -$578.3 million during Q1 2022.
- For the 5-year period, Fulgent Genetics' Enterprise Value averaged around -$411.7 million, with its median value being -$427.0 million (2023).
- Its Enterprise Value has fluctuated over the past 5 years, first plummeted by 169282.0% in 2021, then surged by 5338.24% in 2024.
- Over the past 5 years, Fulgent Genetics' Enterprise Value (Quarter) stood at -$443.4 million in 2021, then dropped by 17.97% to -$523.0 million in 2022, then rose by 18.37% to -$427.0 million in 2023, then soared by 38.6% to -$262.2 million in 2024, then plummeted by 45.3% to -$380.9 million in 2025.
- Its Enterprise Value stands at -$380.9 million for Q3 2025, versus -$297.9 million for Q2 2025 and -$324.7 million for Q1 2025.